ACT Exam  >  ACT Questions  >  A new drug is in its clinical trial phase. Th... Start Learning for Free
A new drug is in its clinical trial phase. The graph below shows the data for participants sleep patterns before medication use and then after using the medication for three months. Series 1 shows the average hours slept a night for each participant prior to medication. Series 2 shows the average hours slept a night for each participant after three months of use. The average hours slept a night was obtained by recording sleep every night for one month, and then finding the average. Patients one through five took a placebo pil, not the actual Moonlight medication. Note: The y-axis is measured in hours slept a night, while the x-axis lists each anonymous patient numerically. 
Q. The overall trend when comparing sleep before and after mediciation use is __________. 
  • a)
    There was not a difference in the average hours slept a night by a patient before the medication use and after the medication use.
  • b)
    Patients who slept the most prior to the medication saw the least increase in hours slept when on the medication. 
  • c)
    Patients who slept the most prior to the medication saw the greatest increase in hours slept when on the medication. 
  • d)
    Patients who slept the least prior to the medication saw the greatest increase in hours slept when on the medication. 
  • e)
    All patients experienced an increase in hours slept when on the medication, except those taking the placebo. 
Correct answer is option 'D'. Can you explain this answer?
Most Upvoted Answer
A new drug is in its clinical trial phase. The graph below shows the d...
Looking at the graph, one will see the patients who slept the least before medication usage (patients 4, 6, and 9), had the largest increase in hours slept. Further, patient 7 and patient 3 had the greatest amount of hours slept prior to medication usage. These two patients had the smallest increase in average sleeping hours. 
Explore Courses for ACT exam

Similar ACT Doubts

Directions:Read the passages and choose the best answer to each question.PassageClinical research has become an important element in the development of modern medicine. Perhaps one of the most widely-debated issues in today’s clinical research is the use of placebos, treatments believed to be biologically ineffective but used anyway for psychological or experimental purposes; an example of a placebo is a sugar pill, which contains no medication. In the realm of clinical research, placebos are used to establish a control group within the pool of research participants. A certain percentage of research patients are administered the test treatment, and another percentage is administered a placebo treatment. Patients are not informed of which percentage they are a part.For various reasons, the use of placebos in clinical research is a controversial issue. Two scientists debate whether the use of placebos is a good or bad practice in research.Scientist 1Placebos are an important aspect of clinical research for many reasons. Not only do they establish a control group for the test treatment in question, but they also help address the issue of mind over matter, which is an important issue when working towards treatment for a particular illness. The body is a powerful life force, with natural recuperative abilities.A placebo encourages such recuperation.Placebos also address the psychological aspect of illness. Because patients are unaware of whether they are receiving treatment or a placebo, the possibility of receiving treatment often provides patients with a psychological boost. The use of placebos addresses the question of whether a person’s positive attitude may be important in recovery from illness. As a result, the placebo effect—a change in the patient’s condition due to the idea of treatment, rather than its biological effectiveness—may be a measurable change in behavior as a result of the belief in treatment.For both their physical and psychological benefits, placebos should be used in clinical research.Scientist 2There are many reasons why placebos shouldn’t be used in clinical research. For example, placebos encourage deception in the doctor-patient relationship. Because this relationship is crucial to the confidence of both the doctor and the patient, and therefore the overall success of the patient’s involvement in a study, placebos not only deceive patients, but can also have an adverse affect on research results. Placebos also violate patients’ autonomy, or their right to choose treatment. While they can choose to be involved in a study, patients are unable to select their own course of treatment because it chosen for them.Some argue that the placebo is worth its implementation in order to evaluate for the occurrence of the placebo effect.However, such action may skew the results of the study. For example, placebo-related changes could be over-estimated.Different illnesses, by definition, will react differently to the placebo. For example, in the instance of chronic pain or mood disorders, it’s possible for patients to show spontaneous improvement. The placebo effect can also result fromcontact with doctors or a respected professional. Patients are vulnerable to their environment, which significantly affects the psychological results of the placebo.Due to its capability to skew research results, the placebo shouldn’t be used in clinical research.Q.An evaluation of several placebo-using studies found that those patients who were involved were not only very trusting of their doctors and medical teams, but they were also more willing to communicate the various effects the treatment was having on them. This finding contradicts evidence stated in which viewpoint?

Directions:Read the passages and choose the best answer to each question.PassageClinical research has become an important element in the development of modern medicine. Perhaps one of the most widely-debated issues in today’s clinical research is the use of placebos, treatments believed to be biologically ineffective but used anyway for psychological or experimental purposes; an example of a placebo is a sugar pill, which contains no medication. In the realm of clinical research, placebos are used to establish a control group within the pool of research participants. A certain percentage of research patients are administered the test treatment, and another percentage is administered a placebo treatment. Patients are not informed of which percentage they are a part.For various reasons, the use of placebos in clinical research is a controversial issue. Two scientists debate whether the use of placebos is a good or bad practice in research.Scientist 1Placebos are an important aspect of clinical research for many reasons. Not only do they establish a control group for the test treatment in question, but they also help address the issue of mind over matter, which is an important issue when working towards treatment for a particular illness. The body is a powerful life force, with natural recuperative abilities.A placebo encourages such recuperation.Placebos also address the psychological aspect of illness. Because patients are unaware of whether they are receiving treatment or a placebo, the possibility of receiving treatment often provides patients with a psychological boost. The use of placebos addresses the question of whether a person’s positive attitude may be important in recovery from illness. As a result, the placebo effect—a change in the patient’s condition due to the idea of treatment, rather than its biological effectiveness—may be a measurable change in behavior as a result of the belief in treatment.For both their physical and psychological benefits, placebos should be used in clinical research.Scientist 2There are many reasons why placebos shouldn’t be used in clinical research. For example, placebos encourage deception in the doctor-patient relationship. Because this relationship is crucial to the confidence of both the doctor and the patient, and therefore the overall success of the patient’s involvement in a study, placebos not only deceive patients, but can also have an adverse affect on research results. Placebos also violate patients’ autonomy, or their right to choose treatment. While they can choose to be involved in a study, patients are unable to select their own course of treatment because it chosen for them.Some argue that the placebo is worth its implementation in order to evaluate for the occurrence of the placebo effect.However, such action may skew the results of the study. For example, placebo-related changes could be over-estimated.Different illnesses, by definition, will react differently to the placebo. For example, in the instance of chronic pain or mood disorders, it’s possible for patients to show spontaneous improvement. The placebo effect can also result fromcontact with doctors or a respected professional. Patients are vulnerable to their environment, which significantly affects the psychological results of the placebo.Due to its capability to skew research results, the placebo shouldn’t be used in clinical research.Q.Scientist 1’s viewpoint implies that Scientist 2’s viewpoint would be weakened by which of the following observations?

Directions:Read the passages and choose the best answer to each question.PassageClinical research has become an important element in the development of modern medicine. Perhaps one of the most widely-debated issues in today’s clinical research is the use of placebos, treatments believed to be biologically ineffective but used anyway for psychological or experimental purposes; an example of a placebo is a sugar pill, which contains no medication. In the realm of clinical research, placebos are used to establish a control group within the pool of research participants. A certain percentage of research patients are administered the test treatment, and another percentage is administered a placebo treatment. Patients are not informed of which percentage they are a part.For various reasons, the use of placebos in clinical research is a controversial issue. Two scientists debate whether the use of placebos is a good or bad practice in research.Scientist 1Placebos are an important aspect of clinical research for many reasons. Not only do they establish a control group for the test treatment in question, but they also help address the issue of mind over matter, which is an important issue when working towards treatment for a particular illness. The body is a powerful life force, with natural recuperative abilities.A placebo encourages such recuperation.Placebos also address the psychological aspect of illness. Because patients are unaware of whether they are receiving treatment or a placebo, the possibility of receiving treatment often provides patients with a psychological boost. The use of placebos addresses the question of whether a person’s positive attitude may be important in recovery from illness. As a result, the placebo effect—a change in the patient’s condition due to the idea of treatment, rather than its biological effectiveness—may be a measurable change in behavior as a result of the belief in treatment.For both their physical and psychological benefits, placebos should be used in clinical research.Scientist 2There are many reasons why placebos shouldn’t be used in clinical research. For example, placebos encourage deception in the doctor-patient relationship. Because this relationship is crucial to the confidence of both the doctor and the patient, and therefore the overall success of the patient’s involvement in a study, placebos not only deceive patients, but can also have an adverse affect on research results. Placebos also violate patients’ autonomy, or their right to choose treatment. While they can choose to be involved in a study, patients are unable to select their own course of treatment because it chosen for them.Some argue that the placebo is worth its implementation in order to evaluate for the occurrence of the placebo effect.However, such action may skew the results of the study. For example, placebo-related changes could be over-estimated.Different illnesses, by definition, will react differently to the placebo. For example, in the instance of chronic pain or mood disorders, it’s possible for patients to show spontaneous improvement. The placebo effect can also result fromcontact with doctors or a respected professional. Patients are vulnerable to their environment, which significantly affects the psychological results of the placebo.Due to its capability to skew research results, the placebo shouldn’t be used in clinical research.Q.Which of the following is most consistent with the reasons supporting the use of placebos in clinical research?Many patients administered a placebo during a study

Directions:Read the passages and choose the best answer to each question.PassageClinical research has become an important element in the development of modern medicine. Perhaps one of the most widely-debated issues in today’s clinical research is the use of placebos, treatments believed to be biologically ineffective but used anyway for psychological or experimental purposes; an example of a placebo is a sugar pill, which contains no medication. In the realm of clinical research, placebos are used to establish a control group within the pool of research participants. A certain percentage of research patients are administered the test treatment, and another percentage is administered a placebo treatment. Patients are not informed of which percentage they are a part.For various reasons, the use of placebos in clinical research is a controversial issue. Two scientists debate whether the use of placebos is a good or bad practice in research.Scientist 1Placebos are an important aspect of clinical research for many reasons. Not only do they establish a control group for the test treatment in question, but they also help address the issue of mind over matter, which is an important issue when working towards treatment for a particular illness. The body is a powerful life force, with natural recuperative abilities.A placebo encourages such recuperation.Placebos also address the psychological aspect of illness. Because patients are unaware of whether they are receiving treatment or a placebo, the possibility of receiving treatment often provides patients with a psychological boost. The use of placebos addresses the question of whether a person’s positive attitude may be important in recovery from illness. As a result, the placebo effect—a change in the patient’s condition due to the idea of treatment, rather than its biological effectiveness—may be a measurable change in behavior as a result of the belief in treatment.For both their physical and psychological benefits, placebos should be used in clinical research.Scientist 2There are many reasons why placebos shouldn’t be used in clinical research. For example, placebos encourage deception in the doctor-patient relationship. Because this relationship is crucial to the confidence of both the doctor and the patient, and therefore the overall success of the patient’s involvement in a study, placebos not only deceive patients, but can also have an adverse affect on research results. Placebos also violate patients’ autonomy, or their right to choose treatment. While they can choose to be involved in a study, patients are unable to select their own course of treatment because it chosen for them.Some argue that the placebo is worth its implementation in order to evaluate for the occurrence of the placebo effect.However, such action may skew the results of the study. For example, placebo-related changes could be over-estimated.Different illnesses, by definition, will react differently to the placebo. For example, in the instance of chronic pain or mood disorders, it’s possible for patients to show spontaneous improvement. The placebo effect can also result fromcontact with doctors or a respected professional. Patients are vulnerable to their environment, which significantly affects the psychological results of the placebo.Due to its capability to skew research results, the placebo shouldn’t be used in clinical research.Q.According to Scientist 2’s viewpoint, which of the following observations provides the strongest argument against using placebos in clinical research?

Top Courses for ACT

A new drug is in its clinical trial phase. The graph below shows the data for participants sleep patterns before medication use and then after using the medication for three months. Series 1 shows the average hours slept a night for each participant prior to medication. Series 2 shows the average hours slept a night for each participant after three months of use. The average hours slept a night was obtained by recording sleep every night for one month, and then finding the average. Patients one through five took a placebo pil, not the actual Moonlight medication. Note: The y-axis is measured in hours slept a night, while the x-axis lists each anonymous patient numerically.Q.The overall trend when comparing sleep before and after mediciation use is __________.a)There was not a difference in the average hours slept a night by a patient before the medication use and after the medication use.b)Patients who slept the most prior to the medication saw the least increase in hours slept when on the medication.c)Patients who slept the most prior to the medication saw the greatest increase in hours slept when on the medication.d)Patients who slept the least prior to the medication saw the greatest increase in hours slept when on the medication.e)All patients experienced an increase in hours slept when on the medication, except those taking the placebo.Correct answer is option 'D'. Can you explain this answer?
Question Description
A new drug is in its clinical trial phase. The graph below shows the data for participants sleep patterns before medication use and then after using the medication for three months. Series 1 shows the average hours slept a night for each participant prior to medication. Series 2 shows the average hours slept a night for each participant after three months of use. The average hours slept a night was obtained by recording sleep every night for one month, and then finding the average. Patients one through five took a placebo pil, not the actual Moonlight medication. Note: The y-axis is measured in hours slept a night, while the x-axis lists each anonymous patient numerically.Q.The overall trend when comparing sleep before and after mediciation use is __________.a)There was not a difference in the average hours slept a night by a patient before the medication use and after the medication use.b)Patients who slept the most prior to the medication saw the least increase in hours slept when on the medication.c)Patients who slept the most prior to the medication saw the greatest increase in hours slept when on the medication.d)Patients who slept the least prior to the medication saw the greatest increase in hours slept when on the medication.e)All patients experienced an increase in hours slept when on the medication, except those taking the placebo.Correct answer is option 'D'. Can you explain this answer? for ACT 2025 is part of ACT preparation. The Question and answers have been prepared according to the ACT exam syllabus. Information about A new drug is in its clinical trial phase. The graph below shows the data for participants sleep patterns before medication use and then after using the medication for three months. Series 1 shows the average hours slept a night for each participant prior to medication. Series 2 shows the average hours slept a night for each participant after three months of use. The average hours slept a night was obtained by recording sleep every night for one month, and then finding the average. Patients one through five took a placebo pil, not the actual Moonlight medication. Note: The y-axis is measured in hours slept a night, while the x-axis lists each anonymous patient numerically.Q.The overall trend when comparing sleep before and after mediciation use is __________.a)There was not a difference in the average hours slept a night by a patient before the medication use and after the medication use.b)Patients who slept the most prior to the medication saw the least increase in hours slept when on the medication.c)Patients who slept the most prior to the medication saw the greatest increase in hours slept when on the medication.d)Patients who slept the least prior to the medication saw the greatest increase in hours slept when on the medication.e)All patients experienced an increase in hours slept when on the medication, except those taking the placebo.Correct answer is option 'D'. Can you explain this answer? covers all topics & solutions for ACT 2025 Exam. Find important definitions, questions, meanings, examples, exercises and tests below for A new drug is in its clinical trial phase. The graph below shows the data for participants sleep patterns before medication use and then after using the medication for three months. Series 1 shows the average hours slept a night for each participant prior to medication. Series 2 shows the average hours slept a night for each participant after three months of use. The average hours slept a night was obtained by recording sleep every night for one month, and then finding the average. Patients one through five took a placebo pil, not the actual Moonlight medication. Note: The y-axis is measured in hours slept a night, while the x-axis lists each anonymous patient numerically.Q.The overall trend when comparing sleep before and after mediciation use is __________.a)There was not a difference in the average hours slept a night by a patient before the medication use and after the medication use.b)Patients who slept the most prior to the medication saw the least increase in hours slept when on the medication.c)Patients who slept the most prior to the medication saw the greatest increase in hours slept when on the medication.d)Patients who slept the least prior to the medication saw the greatest increase in hours slept when on the medication.e)All patients experienced an increase in hours slept when on the medication, except those taking the placebo.Correct answer is option 'D'. Can you explain this answer?.
Solutions for A new drug is in its clinical trial phase. The graph below shows the data for participants sleep patterns before medication use and then after using the medication for three months. Series 1 shows the average hours slept a night for each participant prior to medication. Series 2 shows the average hours slept a night for each participant after three months of use. The average hours slept a night was obtained by recording sleep every night for one month, and then finding the average. Patients one through five took a placebo pil, not the actual Moonlight medication. Note: The y-axis is measured in hours slept a night, while the x-axis lists each anonymous patient numerically.Q.The overall trend when comparing sleep before and after mediciation use is __________.a)There was not a difference in the average hours slept a night by a patient before the medication use and after the medication use.b)Patients who slept the most prior to the medication saw the least increase in hours slept when on the medication.c)Patients who slept the most prior to the medication saw the greatest increase in hours slept when on the medication.d)Patients who slept the least prior to the medication saw the greatest increase in hours slept when on the medication.e)All patients experienced an increase in hours slept when on the medication, except those taking the placebo.Correct answer is option 'D'. Can you explain this answer? in English & in Hindi are available as part of our courses for ACT. Download more important topics, notes, lectures and mock test series for ACT Exam by signing up for free.
Here you can find the meaning of A new drug is in its clinical trial phase. The graph below shows the data for participants sleep patterns before medication use and then after using the medication for three months. Series 1 shows the average hours slept a night for each participant prior to medication. Series 2 shows the average hours slept a night for each participant after three months of use. The average hours slept a night was obtained by recording sleep every night for one month, and then finding the average. Patients one through five took a placebo pil, not the actual Moonlight medication. Note: The y-axis is measured in hours slept a night, while the x-axis lists each anonymous patient numerically.Q.The overall trend when comparing sleep before and after mediciation use is __________.a)There was not a difference in the average hours slept a night by a patient before the medication use and after the medication use.b)Patients who slept the most prior to the medication saw the least increase in hours slept when on the medication.c)Patients who slept the most prior to the medication saw the greatest increase in hours slept when on the medication.d)Patients who slept the least prior to the medication saw the greatest increase in hours slept when on the medication.e)All patients experienced an increase in hours slept when on the medication, except those taking the placebo.Correct answer is option 'D'. Can you explain this answer? defined & explained in the simplest way possible. Besides giving the explanation of A new drug is in its clinical trial phase. The graph below shows the data for participants sleep patterns before medication use and then after using the medication for three months. Series 1 shows the average hours slept a night for each participant prior to medication. Series 2 shows the average hours slept a night for each participant after three months of use. The average hours slept a night was obtained by recording sleep every night for one month, and then finding the average. Patients one through five took a placebo pil, not the actual Moonlight medication. Note: The y-axis is measured in hours slept a night, while the x-axis lists each anonymous patient numerically.Q.The overall trend when comparing sleep before and after mediciation use is __________.a)There was not a difference in the average hours slept a night by a patient before the medication use and after the medication use.b)Patients who slept the most prior to the medication saw the least increase in hours slept when on the medication.c)Patients who slept the most prior to the medication saw the greatest increase in hours slept when on the medication.d)Patients who slept the least prior to the medication saw the greatest increase in hours slept when on the medication.e)All patients experienced an increase in hours slept when on the medication, except those taking the placebo.Correct answer is option 'D'. Can you explain this answer?, a detailed solution for A new drug is in its clinical trial phase. The graph below shows the data for participants sleep patterns before medication use and then after using the medication for three months. Series 1 shows the average hours slept a night for each participant prior to medication. Series 2 shows the average hours slept a night for each participant after three months of use. The average hours slept a night was obtained by recording sleep every night for one month, and then finding the average. Patients one through five took a placebo pil, not the actual Moonlight medication. Note: The y-axis is measured in hours slept a night, while the x-axis lists each anonymous patient numerically.Q.The overall trend when comparing sleep before and after mediciation use is __________.a)There was not a difference in the average hours slept a night by a patient before the medication use and after the medication use.b)Patients who slept the most prior to the medication saw the least increase in hours slept when on the medication.c)Patients who slept the most prior to the medication saw the greatest increase in hours slept when on the medication.d)Patients who slept the least prior to the medication saw the greatest increase in hours slept when on the medication.e)All patients experienced an increase in hours slept when on the medication, except those taking the placebo.Correct answer is option 'D'. Can you explain this answer? has been provided alongside types of A new drug is in its clinical trial phase. The graph below shows the data for participants sleep patterns before medication use and then after using the medication for three months. Series 1 shows the average hours slept a night for each participant prior to medication. Series 2 shows the average hours slept a night for each participant after three months of use. The average hours slept a night was obtained by recording sleep every night for one month, and then finding the average. Patients one through five took a placebo pil, not the actual Moonlight medication. Note: The y-axis is measured in hours slept a night, while the x-axis lists each anonymous patient numerically.Q.The overall trend when comparing sleep before and after mediciation use is __________.a)There was not a difference in the average hours slept a night by a patient before the medication use and after the medication use.b)Patients who slept the most prior to the medication saw the least increase in hours slept when on the medication.c)Patients who slept the most prior to the medication saw the greatest increase in hours slept when on the medication.d)Patients who slept the least prior to the medication saw the greatest increase in hours slept when on the medication.e)All patients experienced an increase in hours slept when on the medication, except those taking the placebo.Correct answer is option 'D'. Can you explain this answer? theory, EduRev gives you an ample number of questions to practice A new drug is in its clinical trial phase. The graph below shows the data for participants sleep patterns before medication use and then after using the medication for three months. Series 1 shows the average hours slept a night for each participant prior to medication. Series 2 shows the average hours slept a night for each participant after three months of use. The average hours slept a night was obtained by recording sleep every night for one month, and then finding the average. Patients one through five took a placebo pil, not the actual Moonlight medication. Note: The y-axis is measured in hours slept a night, while the x-axis lists each anonymous patient numerically.Q.The overall trend when comparing sleep before and after mediciation use is __________.a)There was not a difference in the average hours slept a night by a patient before the medication use and after the medication use.b)Patients who slept the most prior to the medication saw the least increase in hours slept when on the medication.c)Patients who slept the most prior to the medication saw the greatest increase in hours slept when on the medication.d)Patients who slept the least prior to the medication saw the greatest increase in hours slept when on the medication.e)All patients experienced an increase in hours slept when on the medication, except those taking the placebo.Correct answer is option 'D'. Can you explain this answer? tests, examples and also practice ACT tests.
Explore Courses for ACT exam

Top Courses for ACT

Explore Courses
Signup for Free!
Signup to see your scores go up within 7 days! Learn & Practice with 1000+ FREE Notes, Videos & Tests.
10M+ students study on EduRev